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AfterearlyoutbreaksinNorthAmericainApril2009,thepandemicinﬂuenzaA(H1N1)virusspreadrapidlyaroundtheworld,and
even some patients developed certain severe complications. We reported one case of hemophagocytic lymphohistiocytosis (HLH)
inducedbyseverepandemicinﬂuenzaA(H1N1)virusinfection.A17-year-oldgirlhadacuteonsetoffever,drycough,rhinorrhea,
and sore throat Her family members and close friends also had the similar symptoms. Anti-infection treatment with penicillin
was given after 8 days of the onset of symptoms in the local hospital, and her chest radiograph showed consolidation of the left
lung. Then, she was sent to the People’s Hospital of Guizhou Province in China and endotracheal intubation were underwent
on the ninth day for acute hypoxic respiratory failure. She was diagnosed with HLH induced by severe pandemic inﬂuenza A
(H1N1) 2009 virus. Oseltamivir, steroids, immunoglobulin, and plasmapheresis were given immediately after admission. After
being treated in the People’s Hospital of Guizhou Province for 16 days, she was discharged. This experience shows that HLH
may be a life-threatening complication for severe pandemic inﬂuenza A (H1N1) 2009 virus infection and responds well to
therapy.
1.Introduction
The ﬁrst case of human infection with pandemic inﬂuenza A
(H1N1) 2009 virus was identiﬁed in Mexico in April 2009.
The ﬁrst three cases of conﬁrmed pandemic virus in China
were reported in May 2009 [1].
Hemophagocytic lymphohistiocytosis (HLH) is a rare
clinical-pathological condition, which is characterized by the
activation of the mononuclear phagocyte system, along with
the hemophagocytosis in the reticuloendothelial systems.
The rare case of HLH induced by pandemic inﬂuenza
A (H1N1) 2009 virus infection was reported, and it was
successfully treated.
2. Case Presentation
After catching a cold, a 17-year-old, 160cm height, 40kg
weight, previously healthy girl had acute onset of fever,
fatigue, sore throat, and rhinorrhea for 8 days and dyspnea
for 3 days. Then, she was sent to the emergency department
of a local hospital for medical help on January 6, 2010.
Though conventional medications were given to the patient,
no obvious symptomatic relief was obtained. The next day,
she was sent to the emergency department of the People’s
Hospital of Guizhou Province on account of persistent fever.
On examination, she was conscious and well oriented.
Her temperature was 40◦C–40.5◦C, respiratory rate was 382 Case Reports in Medicine
Table 1: Laboratory test results of the case on diﬀerent days.
Variable 01/07/2010 01/08/2010 01/14/2010 01/20/2010
Days in the People’s Hospital of Guizhou Province 1 2 7 13
Pandemic inﬂuenza A (H1N1) 2009 virus (RT-PCR) — Positive Negative —
White blood cell (cells/L) 2.17 ×109 3.82 ×109 13.24 ×109 8.88
Diﬀerential count (%)
Neutrophils 22.5 74.2 86.5 68.4
Lymphocytes 76.5 7.9 8.8 24.1
Red blood cell (cells/L) 4.69 ×1012 2.92 ×1012 3.62 × 1012 4.71 ×1012
Hemoglobin (g/L) 116 75 103 127
Platelet (cells/L) 46 ×109 19 ×109 102 ×109 122 ×109
C-reactive protein (mg/L) 158.30 175.50 16.20 9.2
Albumin (g/L) 30.3 18.8 38.1 36.9
Triglyceride (mmol/L) — 3.13 1.76 1.68
Creatinine (umol/L) 190.7 332.8 82.6 66.1
Urea nitrogen (mmol/L) 8.4 21.3 10.8 6.5
Alanine transaminase(u/L) 52 56 32 14
Direct bilirubin (mol/L) 12.7 11.9 5.9 5.0
NK-cell activity — 2% 7.5% 20%
Blood cultures Negative Negative Negative Negative
“—”Denotes no data.
per minute, pulse rate was 144 beats per minute, blood
pressure was 102/70mmHg, and oxygenation saturation was
90% while she was given an oxygen mask with 8 liters per
minute oxygen ﬂow. Auscultation revealed bilateral rales and
regular heart sounds, and the spleen tip was soft and barely
palpable under the left rib margin. Computed tomographic
(CT)scanningshowedconsolidationandground-glassopac-
ities of left lung. Laboratory tests revealed white blood
cell (WBC) 2.17 × 109cells/L, hemoglobin 116g/L, platelet
46 × 109cells/l, and C-reactive protein (CRP) 158.30mg/L
(Table 1). Arterial oxygen tension/inspired oxygen fraction
ratio (PaO2/FiO2) was lowered to 94.2, so she received
intubation and mechanical ventilation and then transferred
to the intensive care unit (ICU). On January 8, WBC count
and CRP level were slightly increased, while hemoglobin and
plateletobviouslydecreased.Triglycerideswere3.13mmol/L,
NK-cell activity was low (determined by ﬂow cytometry,
normal range was 7∼40%) [2], repeated blood cultures were
negative, ultrasound investigation revealed splenomegaly
(the length is 13.1cm, and the expected length is 11-
12cm), and her bone marrow smear showed that histiocytes
were engulﬁng blood cells (Figure 1). Real-time reverse
transcriptase-polymerase chain reaction (RT-PCR) of throat
swab specimens for pandemic inﬂuenza A (H1N1) 2009
virus was positive, which was performed in the laboratory
of the Guiyang Centers for Disease Prevention and Control.
She was diagnosed with HLH induced by severe pandemic
inﬂuenza A (H1N1) 2009 virus.
Shewastreatedwithhigh-doseoseltamivir(150mgtwice
daily, for 5 days, following 75mg twice daily, 2 days), high-
dose immunoglobulin (20g once daily, 5 days), plasma-
pheresis (every other day, 2 days), and methylprednisolone
(40mg twice daily, 6 days). She was extubated on January 13.
Figure 1: Bone marrow smear showed clasmatocytes engulﬁng
blood cells (Wright’s staining, 10 ×100).
The next day, the retest of throat swab specimens for
pandemic inﬂuenza A (H1N1) 2009 virus by RT-PCR was
negative.OnJanuary19,hertemperaturedroppedto38.2◦C,
while platelet increased to 108 × 109cells/L and triglycerides
decreased to 1.20mmol/L. All the results suggested that her
HLH had already has improved, indicating that HLH might
beinducedbyH1N1infection.Shewastransferredtotheres-
piratory department for left small pleural eﬀusion after her
fever has improved and left lung consolidation resolved. On
January23,thepatientalmostrecoveredandwasdischarged.
3. Discussion
This case was diagnosed as pandemic inﬂuenza A (H1N1)
2009 virus infection by RT-PCR at the 10th day afterCase Reports in Medicine 3
symptom onset. Soon after, she had several conditions such
as fever, splenomegaly, cytopenias, hypertriglyceridemia,
haemophagocytosis in her bone marrow, and low NK-
cell activity. According to the diagnostic criteria made by
Histiocyte Society, HLH is deﬁned by the presence of at least
ﬁve of the following criteria: (1) fever, (2) splenomegaly,
(3) bicytopenia, (4) hypertriglyceridemia and/or hypoﬁb-
rinogenemia, (5) haemophagocytosis, (6) low/absent NK-
cell activity, (7) hyperferritinemia, and (8) high-soluble
interleukin-2 receptor levels [3]. The last two parameters
cannot be determined in our hospital, but the present case
met the former 6 criteria, so she could be diagnosed with
HLH. Since this case did not have other risk factors which
may be associated with HLH except for pandemic 2009
H1N1,shewasﬁnallydiagnosedwithHLHinducedbysevere
pandemic 2009 H1N1 virus infection.
HLH is a life-threatening condition, which can be
classiﬁed into genetic HLH and secondary HLH. Both types
can occur at any age and are associated with increased
mortality. Autosomal gene defects can cause genetic HLH
or other immune deﬁciencies, such as Chediak-Higashi
syndrome, X-linked lymphoproliferative syndrome, and
Griscelli syndrome [4]. Secondary HLH is associated with
exogenous agents (including viruses, bacteria, fungi, par-
asites, and toxins), endogenous products (including those
resulting from tissue damage, metabolic products, and free
radical stress), rheumatic diseases, and malignant diseases
[5]. HLH induced by viral infection was ﬁrst described in
1979 [6]. Apart from H1N1 virus, others such as human
immunodeﬁciency virus (HIV), cytomegalovirus (CMV),
and Epstein-Barr virus (EBV) have been reported to trigger
the disorder [7–9].
The pandemic H1N1 virus is a triple-reassortant inﬂu-
enza virus containing genes from human, swine, and avian
inﬂuenza viruses. Unlike typical seasonal ﬂu patterns, the
pandemic H1N1 virus caused high levels of summer infec-
tions in the northern hemisphere and then even higher levels
of activity during cooler months in this part of the world
[10]. The study launched by Cao et al. showed that 21.4%
of the patients had leukopenia, of which 68.1% of adults
and 92.3% of children had lymphopenia in China. Delayed
treatment with oseltamivir (≥48 hours) is an independent
risk factor for a prolonged period of RT-PCR positive, but
none of the patients reported had thrombocytopenia [11].
The present case had a sharp drop in platelets, and the
possible reason was that it was too late (9 days, far more
than 48 hours after the onset of symptoms) for her to
receive oseltamivir treatment. The patient had developed
HLH induced by H1N1 virus, so this is the reason why
she was in critical condition. Treatment with high-dose
oseltamivir was necessary for her life-threatening situation.
There may be several ways to treat secondary HLH.
High-dose corticosteroids are commonly used due to
the inﬂammatory nature of the condition. Intravenous
immunoglobulin can enhance humoral immunity as an
immunomodulator, which appears to be more eﬀective in
infection-mediated HLH. Plasmapheresis, which was ﬁrst
usedtofurtherdecreasethecytokinestormin1982,[12],was
an eﬀective therapeutic tool for HLH. Apart from cytotoxic
chemotherapy, the comprehensive therapy mentioned above
had been carried out, and a rare hematological complication
of pandemic H1N1 virus infection was successfully cured.
In conclusion, if febrile patients with pandemic H1N1
virus infection are associated with cytopenia, a bone marrow
aspiration is recommended. Once conﬁrmed as HLH cases,
they should be given directed therapy as early as possible.
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